UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ADMA — Adma Biologics, Inc.
CIK 861177
NEW YORK, NY
Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,309,127
-$237,665 QoQ
Shares Held
395,356
+0.4% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 323 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ADMA ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ADMA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,309,127 | 395,356 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,546,792 | 393,651 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,296,344 | 400,019 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,729,535 | 390,828 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,169,312 | 942,851 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,201,144 | 816,590 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,772,667 | 511,526 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,194,238 | 509,967 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,992,332 | 535,987 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,447,294 | 219,287 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $846,130 | 187,197 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $596,528 | 166,628 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $509,692 | 138,128 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $457,203 | 138,128 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||